Robert E. Rydell
Impact in
- Hematology top 0.5%
- Acute Myeloid Leukemia Research
- Chronic Myeloid Leukemia Treatments
- Genetics top 2%
- Chronic Lymphocytic Leukemia Research
- Myeloproliferative Neoplasms: Diagnosis and Treatment
Papers in
-
- Acute Myeloid Leukemia Research 7
- Chronic Myeloid Leukemia Treatments 4
-
- Glutathione Transferases and Polymorphisms 3
- Co-authors
- Risa B. Mann (1 shared paper)Hugh Bonner (1 shared paper)Maurice Barcos (1 shared paper)Richard S. Neiman (1 shared paper)Costan W. Berard (1 shared paper)John M. Bennett (1 shared paper)Martin M. Oken (8 shared papers)F. W. Hoffbauer (1 shared paper)
- Journals
- JNCI Journal of the National Cancer Institute (3 papers)The American Journal of Medicine (3 papers)British Journal of Haematology (2 papers)American Journal of Hematology (2 papers)Cancer (2 papers)
- Partner nations
- United StatesSweden
In The Last Decade
Robert E. Rydell
26 papers receiving 1.7k citations
Robert E. Rydell's Hit Papers
Peers
Comparison fields: 5 of 88
- Hematology 1.1k
- Genetics 476
- Emergency Medicine 230
- Pathology and Forensic Medicine 231
- Hepatology 94
Countries citing papers authored by Robert E. Rydell
This map shows the geographic impact of Robert E. Rydell's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Robert E. Rydell with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Robert E. Rydell more than expected).
Fields of papers citing papers by Robert E. Rydell
This network shows the impact of papers produced by Robert E. Rydell. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Robert E. Rydell. The network helps show where Robert E. Rydell may publish in the future.
Co-authors
The 25 scholars most cited alongside Robert E. Rydell, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 27 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Granulocytic sarcoma: A clinicopathologic study of 61 biopsied cases Hit paper breakdown → | 1981 | 780 |
| 2 | 1988 | 195 | |
| 3 | 1956 | 184 | |
| 4 | 1983 | 121 | |
| 5 | 1980 | 120 | |
| 6 | 1991 | 77 | |
| 7 | 1973 | 66 | |
| 8 | On the correlation between the hepatocarcinogenicity of the carcinogen, N-2-fluorenylacetamide, and its metabolic activation by the rat. | 1972 | 57 |
| 9 | 1991 | 33 | |
| 10 | 1986 | 27 | |
| 11 | Inversion of chromosome 16 and dysplastic eosinophils in accelerated phase of chronic myeloid leukemia. | 1992 | 27 |
| 12 | Structure-activity relationships of N-acylarylhydroxylamines in the rat. | 1970 | 27 |
| 13 | 1971 | 21 | |
| 14 | 1980 | 20 | |
| 15 | 1978 | 19 | |
| 16 | Mammary carcinogenesis in the rat by topical application of fluorenylhydroxamic acids and their acetates. | 1977 | 19 |
| 17 | 1981 | 17 | |
| 18 | Mammary carcinogenesis in the rat by topical application of fluorenylhydroxamic acids. | 1973 | 17 |
| 19 | 1973 | 11 | |
| 20 | Activation of the carcinogen, N-hydroxy-2-fluorenylbenzene-sulfonamide, by desulfonylation to N-2-fluorenylhydroxylamine in vivo. | 1971 | 10 |
About Robert E. Rydell
Robert E. Rydell is a scholar working on Hematology, Molecular Biology, Genetics, Pathology and Forensic Medicine and Oncology, having authored 27 papers that have together received 1.9k indexed citations. Recurring topics across this work include Acute Myeloid Leukemia Research (7 papers), Chronic Myeloid Leukemia Treatments (4 papers), Chronic Lymphocytic Leukemia Research (4 papers), Lymphoma Diagnosis and Treatment (3 papers), Cancer Research and Treatments (3 papers), Glutathione Transferases and Polymorphisms (3 papers), Amino Acid Enzymes and Metabolism (2 papers) and Cancer-related Molecular Pathways (2 papers). The work is most often cited by research in Hematology (1.1k citations), Genetics (476 citations), Emergency Medicine (230 citations), Pathology and Forensic Medicine (231 citations) and Hepatology (94 citations). Robert E. Rydell has collaborated with scholars based in United States and Sweden. Frequent co-authors include Risa B. Mann, Hugh Bonner, Maurice Barcos, Richard S. Neiman, Costan W. Berard, John M. Bennett, Martin M. Oken, F. W. Hoffbauer, Kathy Foucar and Heike Gutmann. Their work appears in journals such as JNCI Journal of the National Cancer Institute, The American Journal of Medicine, British Journal of Haematology, American Journal of Hematology and Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.